Raymond James raises USCB PT after bond portfolio restructuring

Raymond James reiterates "strong buy" on regional lender USCB Financial USCB.O; raises PT to $23 from $22, a 26.2% upside to last close

USCB's securities portfolio restructuring expected to boost EPS by 3.8% and net interest margin by 7 bps from first quarter of fiscal year 2026, brokerage says

USCB last week sold $44.6 million of low-yield securities to boost profitability, which is expected to result in a $5.6 million after-tax loss in Q4 2025

Brokerage views the net interest margin and EPS benefits as outweighing the unrealized loss from the restructuring

3 of 5 analysts rate the stock "buy" or "strong buy", 2 "hold"; median PT $21 - data compiled by LSEG

As of last close, USCB up 2.6% YTD